Frankfurt - Delayed Quote EUR
TG Therapeutics, Inc. (NKB2.F)
35.26
+0.90
+(2.63%)
At close: April 25 at 8:06:17 AM GMT+2
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 13.62M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| HUME DANIEL Director | Stock Gift at price 0.00 per share. | Direct | 0 | Mar 17, 2025 |
| CHARNEY LAURENCE NEIL Director | Stock Gift at price 0.00 per share. | Direct | 0 | Mar 10, 2025 |
| WEISS MICHAEL S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 29, 2025 |
| POWER SEAN A Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 29, 2025 |
| POWER SEAN A Chief Financial Officer | Sale at price 28.53 - 30.29 per share. | Direct | 629,382 | Jan 6, 2025 |
| CHARNEY LAURENCE NEIL Director | Stock Gift at price 0.00 per share. | Direct | 0 | Nov 12, 2024 |
| CHARNEY LAURENCE NEIL Director | Sale at price 30.20 per share. | Direct | 754,875 | Nov 11, 2024 |
| LONIAL SAGAR Director | Sale at price 30.44 per share. | Direct | 152,200 | Nov 11, 2024 |
| ECHELARD YANN Director | Sale at price 24.48 per share. | Direct | 489,600 | Nov 5, 2024 |
| LONIAL SAGAR Director | Sale at price 16.39 - 16.87 per share. | Direct | 432,889 | Jun 20, 2024 |
| CHARNEY LAURENCE NEIL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 19, 2024 |
| ECHELARD YANN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 19, 2024 |
| HOBERMAN KENNETH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 19, 2024 |
| HUME DANIEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 19, 2024 |
| LONIAL SAGAR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 19, 2024 |
| LONIAL SAGAR Director | Sale at price 15.94 per share. | Direct | 79,675 | Mar 13, 2024 |
| CHARNEY LAURENCE NEIL Director | Sale at price 15.97 per share. | Direct | 351,340 | Mar 12, 2024 |
| WEISS MICHAEL S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2024 |
| POWER SEAN A Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2024 |
| CHARNEY LAURENCE NEIL Director | Sale at price 19.03 per share. | Direct | 333,025 | Jan 5, 2024 |
| POWER SEAN A Chief Financial Officer | Sale at price 16.91 per share. | Direct | 809,431 | Jan 3, 2024 |
| POWER SEAN A Chief Financial Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 15, 2023 |
| CHARNEY LAURENCE NEIL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 28, 2023 |
| ECHELARD YANN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 28, 2023 |
| HOBERMAN KENNETH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 28, 2023 |
| HUME DANIEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 28, 2023 |
| LONIAL SAGAR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 28, 2023 |
| WEISS MICHAEL S Chief Executive Officer | Purchase at price 10.13 per share. | Direct | 1,013,000 | Aug 11, 2023 |
| LONIAL SAGAR Director | Sale at price 23.37 per share. | Direct | 814,538 | Jun 23, 2023 |
| POWER SEAN A Chief Financial Officer | Sale at price 26.70 per share. | Direct | 1,966,375 | Jun 2, 2023 |
Related Tickers
10VA.F Immunic, Inc.
0.9870
+3.89%
FTD.SG Financière de Tubize SA
116.20
+1.40%
DR6.F ACADIA Pharmaceuticals Inc.
13.03
+2.04%
MDG1.F Medigene AG
0.1485
-1.00%
ICY.F Incyte Corporation
51.80
+1.81%
PRTC.L PureTech Health plc
125.60
-1.72%
TUB.BR Financière de Tubize SA
118.40
+1.72%
22UA.DE BioNTech SE
102.10
-0.10%
TNFA TNF Pharmaceuticals, Inc.
0.2200
+14.58%
RARE Ultragenyx Pharmaceutical Inc.
38.09
+1.20%